For its 7th edition, the Healthtech Summit will return to Lausanne on June 21 - 22, 2016 and will once again focus on showcasing the top 20 medtech and top 20 digital health companies in Europe at the IMD (Institute for Management Development) campus. The 40 presenting companies, represented by their CEOs and carefully selected by our two top tier Selection Committees, will have the opportunity to network with key international investors who can assist them with their global expansion plans. Furthermore, the program will see a balanced and varied succession of corporate presentations, interactive panel discussions on opportunities related to accelerating investment in this sector as well as dedicated networking sessions and a Networking Dinner. The 2016 edition of the Healthtech Summit will focus on Medtech & Diagnostics and Digital Health.
The 2016 Tech Tour Healthtech Entrepreneur Awards will celebrate excellence in entrepreneurship and successful commercialization of innovative health technology in Europe making significant global impact in healthcare. Sapiens was the winner of the 2015 edition, visit our 2015 website.
Download this PDF ‘About the Healthtech Summit’ for more information.
Boston Scientific Europe is the European branch of Boston Scientific Corporation, with offices in 19 countries and a market presence in 52 countries. We transform lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. Our products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. We demonstrate continued commitment to meaningful clinical science by conducting carefully designed clinical studies and by sponsoring studies that seek tailored therapy options to optimize patient outcomes.
Cukierman & Co. Life Sciences (CLS) is a leading specialized investment house delivering high quality, senior level advice to the global Life Sciences sectors, including biotechnology and pharmaceuticals, medical devices and healthcare information technology.